Regeneron Confirms that REGN-COV2 Antibody Cocktail Provided to President Trump Under Compassionate Use Request
October 2, 2020 -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today confirmed that, as announced by the White House Press Secretary, Regeneron provided a single 8 gram dose of REGN-COV2, a cocktail of two monoclonal antibodies, for use by... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 2, 2020 Category: Pharmaceuticals Source Type: clinical trials
Trump administration unveils four executive orders aimed at lowering drug prices
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - July 25, 2020 Category: Cancer & Oncology Source Type: clinical trials
Trump signs `Right to Try Act` aimed at helping terminally ill patients seek drug treatments
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 30, 2018 Category: Cancer & Oncology Source Type: clinical trials
